2018
DOI: 10.1007/s11096-018-0763-0
|View full text |Cite
|
Sign up to set email alerts
|

Impact of medication therapy management on pharmacotherapy safety in an intensive care unit

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

5
23
2
3

Year Published

2020
2020
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 22 publications
(36 citation statements)
references
References 42 publications
5
23
2
3
Order By: Relevance
“…Most of the damages were considered temporary and required intervention. It is in accordance with the results of other studies (16,25) . The positive predictive value showed that the "Abrupt medication stop", "INR > 6" and "Serum glucose <50 mg/dl" had a greater ability to detect an adverse drug event when they were identified in medical records of patients.…”
Section: Discussionsupporting
confidence: 94%
“…Most of the damages were considered temporary and required intervention. It is in accordance with the results of other studies (16,25) . The positive predictive value showed that the "Abrupt medication stop", "INR > 6" and "Serum glucose <50 mg/dl" had a greater ability to detect an adverse drug event when they were identified in medical records of patients.…”
Section: Discussionsupporting
confidence: 94%
“…Due to severity of illness and major changes in organ function, critically ill patients have complex and changing pharmacokinetics and pharmacodynamics, requiring careful evaluation and drug therapy management. Considerable evidence supports the value of having clinical pharmacists (CPs) in ICUs during multidisciplinary critical care 2‐9 . In addition, numerous pharmaceutical economics studies have shown that pharmaceutical intervention can lead to cost savings 10‐18 …”
Section: What Is Known and Objectivementioning
confidence: 99%
“…Once pharmacists identify any DRPs, they report them to physicians and discuss with them the necessary corrective measures. There is ample evidence in the literature supporting the positive impact of pharmacists on the detection and resolution of DRPs, thereby improving patient safety and clinical outcomes 6,24,25 . The results also revealed individual efforts made by a growing number of pharmacists to implement clinical pharmacy services in the hospitals.…”
Section: Discussionmentioning
confidence: 95%
“…This requires pharmacists’ collaboration with other healthcare professionals and the patient in designing, implementing, and monitoring a therapeutic plan with the aim to identify, resolve, and prevent drug‐related problems (DRPs) 3,4 . In developed countries, collaborative practice models, such as medication therapy management have been adopted as frameworks in which pharmacists collaborate with patients, physicians, and other healthcare professionals to provide team‐based care to patients resulting in improved health outcomes 5‐7 …”
Section: Introductionmentioning
confidence: 99%